Overview
This study compares the results of the existing fibrinolysis monitoring technology to the Ultrasound-based viscoelastic hemostasis analysis, a new method, using small amount of extra blood obtained during routine blood draws in surgery patients.
Description
Ultrasound-based viscoelastic hemostasis analysis is a novel POC diagnostic method, which is suitable for operating theatres and emergency rooms.
The novel viscoelastic hemostasis analysis uses ultrasound guided waves to characterize the dynamic changes in viscoelastic properties of a blood sample during coagulation and clot lysis, which will be an assay of hyperfibrinolysis for critically ill patients.
This single-center, prospective, observational pilot study will evaluate the analytical performance as well as compared to conventional viscoelastic testing methods.
Eligibility
PART 1
Inclusion Criteria:
Subject is scheduled for surgery with general surgery Subject is 18 years or order Subject
requires routine TEG measurement
Exclusion Criteria:
Subject with coagulation and fibrinolysis exceeding normal values based on laboratory tests
(including prothrombin time, international normalized ratio, activated partial
thromboplastin time, plasma fibrinogen concentration, D-dimer, platelet count, hemoglobin
concentration, and hematocrit) Subject with any abnormal parameters detected by TEG Subject
with a history of bleeding and thrombosis Subject who has taken any medications that may
affect coagulation, platelet aggregation, or fibrinolysis within the past 10 days
(including non-steroidal anti-inflammatory drugs and aspirin) Residual blood volume <1ml
PART 2
Inclusion Criteria:
Subject is scheduled for surgery with general surgery Subject is 18 years or order Subject
Subjects with detected hyperfibrinolysis (LY30>8%) or non-hyperfibrinolysis(LY30≤8%) based
on TEG.
Exclusion Criteria:
Residual blood volume <1ml